Add to ORKGFollowing medical school and an internal medicine residency in Toronto, and infec-tious diseases training at the New England Medical Center/Tufts University in Boston, Jonathan joined the Division of Infectious Diseases, Department of Medicine at the Ottawa General Hospital in 1995. His research focuses on understanding how HIV damages the immune system and how these insights may lead to new therapies. Jon-athan is currently Professor of Medicine, University of Ottawa and Senior Scientist, Ottawa Hospital Research Institute. He was Editor-in-Chief of CIM from 2010–2015
With the advent and stunning success of combination antiretroviral therapy (ART) to prolong and impr...
The Ontario HIV Treatment Network (OHTN) is a non-profit network which collaborates with health clin...
Once again, Richard Jefferys effortlessly guides us through the challenging landscape of "Research T...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
In 2008, it will have been 25 years since HIV was first isolated from a patient with AIDS. In the ea...
Simon Situma BarasaKenya Polytechnic University College, Nairobi, KenyaAbstract: Radical cure of inf...
As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occ...
In 1985 the Institute of Medicine, National Academy of Sciences devoted its annual meeting to an exp...
The continuing AIDS pandemic reminds us that despite the unrelenting quest for knowledge since the e...
The World Health Organization estimates that in 2018 almost 40 million people worldwide are infected...
We surveyed graduates of a longitudinal medical school human immunodeficiency virus curriculum to ev...
The focus of this PhD is to demonstrate how routinely collected de-identified patient information ca...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
With the advent and stunning success of combination antiretroviral therapy (ART) to prolong and impr...
The Ontario HIV Treatment Network (OHTN) is a non-profit network which collaborates with health clin...
Once again, Richard Jefferys effortlessly guides us through the challenging landscape of "Research T...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 i...
In 2008, it will have been 25 years since HIV was first isolated from a patient with AIDS. In the ea...
Simon Situma BarasaKenya Polytechnic University College, Nairobi, KenyaAbstract: Radical cure of inf...
As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occ...
In 1985 the Institute of Medicine, National Academy of Sciences devoted its annual meeting to an exp...
The continuing AIDS pandemic reminds us that despite the unrelenting quest for knowledge since the e...
The World Health Organization estimates that in 2018 almost 40 million people worldwide are infected...
We surveyed graduates of a longitudinal medical school human immunodeficiency virus curriculum to ev...
The focus of this PhD is to demonstrate how routinely collected de-identified patient information ca...
Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment i...
With the advent and stunning success of combination antiretroviral therapy (ART) to prolong and impr...
The Ontario HIV Treatment Network (OHTN) is a non-profit network which collaborates with health clin...
Once again, Richard Jefferys effortlessly guides us through the challenging landscape of "Research T...